Antithrombin III deficiency historical perspective

Jump to navigation Jump to search

Antithrombin III deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Antithrombin III deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Antithrombin III deficiency historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Antithrombin III deficiency historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Antithrombin III deficiency historical perspective

CDC on Antithrombin III deficiency historical perspective

Antithrombin III deficiency historical perspective in the news

Blogs on Antithrombin III deficiency historical perspective

Directions to Hospitals Treating Antithrombin III deficiency

Risk calculators and risk factors for Antithrombin III deficiency historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • Antithrombin deficiency was first Described in 1965 Olav Egeberg.[1]
  • it was observed in an Scandinavian family with multiple venous embolism.

References

  1. Abildgaard U (2001). "[Olav Egeberg--hereditary antithrombin deficiency and thrombophilia]". Tidsskr Nor Laegeforen. 121 (5): 604–5. PMID 11301618.

Template:WH Template:WS